Research and Development

Showing 15 posts of 9604 posts found.

aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018 Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …
old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018 Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …
gw_pharma

GW Pharma boasts new positive data, readying for approval

January 25, 2018 Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …
influenza_dan_higgins_douglas_jordan_uscdcp

New vaccine provides universal protection against influenza A, study finds

January 24, 2018 Research and Development Georgia State University, Vaccine, flu, influenza, pharma

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …
shutterstock_92671375

US court upholds ruling that J&J’s Remicade patent is invalid

January 24, 2018 Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma

The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …
shutterstock_138095450

New York City launches $500 million lawsuit against big pharma over opioid crisis

January 24, 2018 Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …
lilly_entrance_web

Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup

January 24, 2018 Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …
shutterstock_157775444

NICE recommends for online and mobile depression programme for trial on NHS

January 24, 2018 Research and Development Deprexis, NHS, NICE, app, depression, pharma

NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of …
teva_copy

More woes for Teva as two late-stage asthma studies bomb

January 23, 2018 Manufacturing and Production, Research and Development Teva, asthma, pharma

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …
nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …
gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018 Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …
astrazeneca-sign

AstraZeneca expands drug discovery collaboration with X-Chem

January 18, 2018 Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
pregnancy_credit_needed

Evidence mounts yet again against efficacy of common morning sickness pill

January 18, 2018 Research and Development Diclegis, morning sickness, pharma

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine  (Diclegis, Diclectin), as new study data reveals …
The Gateway to Local Adoption Series

Latest content